Stay updated on KTE-C19 + Atezolizumab in DLBCL Clinical Trial

Sign up to get notified when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-08T13:45:43.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:20:47.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version of the study, with significant changes including the removal of detailed objectives and criteria for a clinical trial involving KTE-C19 and atezolizumab for refractory diffuse large B-cell lymphoma, while retaining some core information about the study design and collaborators.
    Difference
    16%
    Check dated 2025-04-16T20:28:57.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T14:13:25.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-02T00:13:25.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-25T15:24:10.000Z thumbnail image

Stay in the know with updates to KTE-C19 + Atezolizumab in DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.